Publications

Chronic prescription opioid use in pregnancy in the United States.

Author(s): Straub L, Huybrechts KF, Hernández-Díaz S, Zhu Y, Vine S, Desai RJ, Gray KJ, Bateman BTJournal: Pharmacoepidemiol Drug SafPMID: 33428239 August 2021

To evaluate chronic opioid utilization patterns during pregnancy using nationwide data from publicly and commercially insured women.

Safety of Tenofovir Disoproxil Fumarate (TDF) for Pregnant Women facing the COVID-19 Pandemic.

Author(s): Hernández-Díaz S, Bateman BT, Straub L, Zhu Y, Mogun H, Fischer M, Huybrechts KFJournal: Am J EpidemiolPMID: 33847737 August 2021

We assessed the teratogenicity of tenofovir, a human immunodeficiency virus (HIV) drug similar to remdesivir currently being evaluated for the…

Hydroxychloroquine early in pregnancy and risk of birth defects: absence of evidence is not the same as evidence of absence.

Author(s): Huybrechts KF, Bateman BT, Hernández-Díaz SJournal: Am J Obstet GynecolPMID: 33434554 August 2021

Chronic prescription opioid use in pregnancy in the United States.

Safety of Tenofovir Disoproxil Fumarate (TDF) for Pregnant Women facing the COVID-19 Pandemic.

Hydroxychloroquine early in pregnancy and risk of birth defects: absence of evidence is not the same as evidence of absence.

Development and Validation of a Pediatric Comorbidity Index.

Active Surveillance of the Safety of Medications Used During Pregnancy.

Validation of a claims-based algorithm to identify pregestational diabetes among pregnant women in the United States.